Question 1

What is Zenas BioPharma?

Accepted Answer

Zenas BioPharma is a Entity.

Question 2

How often does Zenas BioPharma appear in global news?

Accepted Answer

Tracked across 6 news events drawn from 37 articles.

Question 3

When was Zenas BioPharma first tracked by Ergen?

Accepted Answer

First tracked on Apr 17, 2025.

Question 4

When was Zenas BioPharma last mentioned in news?

Accepted Answer

Last active on May 25, 2026.

Question 5

What is Zenas BioPharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: -53 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Zenas BioPharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 6 events.

Question 7

What is the most recent event involving Zenas BioPharma?

Accepted Answer

Zenas BioPharma Class Action Lawsuit (Apr 23, 2025, 6 articles).

Question 8

How did the "Zenas BioPharma Class Action Lawsuit" event impact Zenas BioPharma?

Accepted Answer

Zenas BioPharma is the defendant in a class action lawsuit, accused of making materially false and misleading statements regarding its funding capabilities during its September 2024 IPO.

Question 9

How did the "Zenas BioPharma IPO Securities Fraud" event impact Zenas BioPharma?

Accepted Answer

Zenas BioPharma is the defendant in a class action lawsuit for allegedly misleading investors about its financial stability during its September 2024 IPO. Its stock price has fallen nearly 49% since the IPO.

Question 10

How did the "Zenas BioPharma Securities Class Action" event impact Zenas BioPharma?

Accepted Answer

Zenas BioPharma is facing a class action securities lawsuit for allegedly making false and misleading statements regarding its financial sustainability during its September 2024 IPO.

Question 11

How did the "Zenas BioPharma IPO Class Action" event impact Zenas BioPharma?

Accepted Answer

Zenas BioPharma is facing a federal securities class action lawsuit for allegedly overstating its ability to fund operations using existing cash and IPO proceeds, leading to investor damages.

Question 12

How did the "Zenas BioPharma IPO Securities Lawsuit" event impact Zenas BioPharma?

Accepted Answer

Zenas BioPharma is facing a securities class action lawsuit for allegedly making false and misleading statements in its September 2024 IPO registration statement, which could lead to financial damages and reputational harm.

Question 13

How did the "Santhera Pharmaceuticals Appoints Orlando Oliveira CEO" event impact Zenas BioPharma?

Accepted Answer

Orlando Oliveira previously served as Chief Commercial Officer of Zenas BioPharma, where he supported its NASDAQ IPO and strategic licensing transactions.

Question 14

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.